Cumberland Pharmaceuticals Launches Promotion of Totect(R) in The U.S. for Emergency Oncology Intervention

NASHVILLE, Tenn. and BURTON ON TRENT, England, Sept. 25, 2017 -- (Healthcare Sales & Marketing Network) -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX, 'Cumberland') and Clinigen Group plc (AIM:CLIN, 'Clinigen'), announced today the promotional launch o... Biopharmaceuticals, Oncology, Product Launch Cumberland Pharmaceuticals, Totect, dexrazoxane, anthracycline, extravasation
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news